Report for Q3 2026
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(605033)"Shaanxi Meibang Pharmaceutical Group Co., Ltd."Report for Q3 2026
Filed with SSE · Stock code 605033 ·
6ix is reading this filing.
View original source (Shanghai Stock Exchange)Shaanxi Meibang Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Shaanxi Meibang Pharmaceutical
- Announcement on Providing Guarantees for Wholly-owned Subsidiaries
- Announcement on Capital Increase in a Wholly-owned Subsidiary and Establishment of a Hong Kong Wholly-owned Subsidiary
- Announcement on the Results of Shareholding Reduction by Shareholders
- Announcement on the Results of Shareholding Reduction by Certain Shareholders
- Announcement on Change of Shareholder Name
Follow Shaanxi Meibang Pharmaceutical into a list and get an email when it puts out news.
Follow Shaanxi Meibang Pharmaceutical